DK1137409T3 - Præparater og fremgangsmåde til lindring af human kvindelig seksuel dysfunktion - Google Patents

Præparater og fremgangsmåde til lindring af human kvindelig seksuel dysfunktion

Info

Publication number
DK1137409T3
DK1137409T3 DK99967277T DK99967277T DK1137409T3 DK 1137409 T3 DK1137409 T3 DK 1137409T3 DK 99967277 T DK99967277 T DK 99967277T DK 99967277 T DK99967277 T DK 99967277T DK 1137409 T3 DK1137409 T3 DK 1137409T3
Authority
DK
Denmark
Prior art keywords
methods
female sexual
sexual dysfunction
preparations
human female
Prior art date
Application number
DK99967277T
Other languages
Danish (da)
English (en)
Inventor
James L Yeager
Nadir Buyuktimkin
Servet Buyuktimkin
Original Assignee
Nexmed Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexmed Holdings Inc filed Critical Nexmed Holdings Inc
Application granted granted Critical
Publication of DK1137409T3 publication Critical patent/DK1137409T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99967277T 1998-12-10 1999-12-10 Præparater og fremgangsmåde til lindring af human kvindelig seksuel dysfunktion DK1137409T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/208,965 US6486207B2 (en) 1998-12-10 1998-12-10 Compositions and methods for amelioration of human female sexual dysfunction
PCT/US1999/029471 WO2000033825A2 (en) 1998-12-10 1999-12-10 Compositions and methods for amelioration of human female sexual dysfunction

Publications (1)

Publication Number Publication Date
DK1137409T3 true DK1137409T3 (da) 2004-08-02

Family

ID=22776778

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99967277T DK1137409T3 (da) 1998-12-10 1999-12-10 Præparater og fremgangsmåde til lindring af human kvindelig seksuel dysfunktion

Country Status (19)

Country Link
US (1) US6486207B2 (ko)
EP (1) EP1137409B1 (ko)
JP (1) JP4616480B2 (ko)
KR (1) KR100660239B1 (ko)
CN (1) CN1173700C (ko)
AT (1) ATE265849T1 (ko)
AU (1) AU760112B2 (ko)
BR (1) BR9916076A (ko)
CA (1) CA2354695C (ko)
DE (1) DE69917066T2 (ko)
DK (1) DK1137409T3 (ko)
ES (1) ES2217878T3 (ko)
HK (1) HK1039067B (ko)
HU (1) HU229083B1 (ko)
IL (2) IL143661A0 (ko)
MX (1) MXPA01005748A (ko)
PT (1) PT1137409E (ko)
WO (1) WO2000033825A2 (ko)
ZA (1) ZA200104697B (ko)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
US20050004226A1 (en) * 1998-12-10 2005-01-06 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
US6825234B2 (en) * 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
EA008720B1 (ru) * 1998-12-10 2007-06-29 Нексмед (Холдингс), Инк. Применение композиции на основе простагландина для лечения расстройства сексуального возбуждения у женщин
EP1220666A2 (en) * 1999-04-06 2002-07-10 Zonagen, Inc. Methods for modulating the human sexual response
US20010029268A1 (en) * 1999-07-01 2001-10-11 Thompson Ronald J. Clitoral sensitizing arrangement using compound of menthol and L-arginine
US6702733B1 (en) * 1999-07-01 2004-03-09 40 J's Llc Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds
US20050244520A1 (en) * 1999-07-01 2005-11-03 40J's Llc Topical menthol, or a related cooling compound, to induce lubrication
US6464628B1 (en) * 1999-08-12 2002-10-15 Obtech Medical Ag Mechanical anal incontinence
IL139455A0 (en) * 1999-11-08 2001-11-25 Pfizer Compounds for the treatment of female sexual dysfunction
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
US7105571B2 (en) 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
CA2397922C (en) * 2000-02-10 2009-04-21 Potencia Medical Ag Mechanical impotence treatment apparatus
WO2001047441A2 (en) * 2000-02-14 2001-07-05 Potencia Medical Ag Penile prosthesis
DE60131644T2 (de) * 2000-05-09 2008-10-30 Nitromed, Inc., Lexington Infrarotthermographie und behandlung von sexuellen dysfunktionen
US20020052370A1 (en) * 2000-07-06 2002-05-02 Barber Christopher Gordon Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
GB2372213B (en) * 2000-11-17 2003-07-16 Icebella Enterpises Ltd Applicator and stimulator device
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) * 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US6673841B2 (en) * 2001-12-20 2004-01-06 Whan In Pharm. Co., Ltd. Alprostadil alkyl ester-containing composition for external application
GB0130704D0 (en) * 2001-12-21 2002-02-06 Glaxo Group Ltd New use
AU2003211077A1 (en) * 2002-02-15 2003-09-09 Nexmed (Holdings), Inc. Prostaglandin composition for the treatment of erectile dysfuntion
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
WO2004037225A2 (en) 2002-10-25 2004-05-06 Foamix Ltd. Cosmetic and pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
GB0225908D0 (en) * 2002-11-06 2002-12-11 Pfizer Ltd Treatment of female sexual dysfunction
US7323462B2 (en) 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
CN1771041A (zh) * 2003-03-21 2006-05-10 尼克美制药控股有限公司 治疗勃起功能障碍的前列腺素组合物
AU2004224459A1 (en) * 2003-03-21 2004-10-07 Nexmed (Holdings), Inc. Angiogenesis promotion by prostaglandin compositions and methods
EP1608378A1 (en) * 2003-04-02 2005-12-28 Nexmed (Holdings), Inc. Prostaglandin compositions and their use for the treatment of vasospasm
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
WO2005051960A2 (en) * 2003-11-22 2005-06-09 Midwest Research Laboratories, Llc Hydrocarbyl aminohydrocarbonoates and aminohydrocarbonol hydrocarbonoates as antimicrobial and antiviral agents
EP1720611B1 (de) * 2004-02-16 2010-05-19 ProteoSys AG Diagnostische marker für krebs
US7276486B2 (en) * 2004-03-15 2007-10-02 Kimberly-Clark Worldwide, Inc. Compositions for vaginal treatment
US20050276865A1 (en) * 2004-05-20 2005-12-15 Servet Buyuktimkin Peroxide compounds for the prevention and treatment of sexual dysfunction in humans
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US20070059250A1 (en) * 2005-09-12 2007-03-15 Nawaz Ahmad Sprayable personal lubricant
DK2926847T3 (da) 2005-11-02 2022-07-04 Medicaltree Patents Ltd Implanterbar infusionsapparat med fremførbar og tilbagetrækkelig nål
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
EP3925661A1 (en) 2007-10-11 2021-12-22 Implantica Patent Ltd. Apparatus and system for the treatment of female sexual dysfunction
PL2211984T3 (pl) 2007-10-11 2022-09-05 Implantica Patent Ltd. Urządzenie do leczenia dysfunkcji seksualnych kobiet
US8696543B2 (en) * 2007-10-11 2014-04-15 Kirk Promotion Ltd. Method for controlling flow of intestinal contents in a patient's intestines
WO2009048382A1 (en) * 2007-10-11 2009-04-16 Milux Holding Sa Apparatus for treating female sexual dysfunction
EP3925573A1 (en) 2007-10-11 2021-12-22 Implantica Patent Ltd. A system for treating a sexual dysfunctional female patient
EP3868336B1 (en) * 2007-10-11 2024-05-08 Implantica Patent Ltd. Apparatus for controlling flow in a bodily organ
US8795153B2 (en) 2007-10-11 2014-08-05 Peter Forsell Method for treating female sexual dysfunction
US8992409B2 (en) * 2007-10-11 2015-03-31 Peter Forsell Method for controlling flow in a bodily organ
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
AU2009209514A1 (en) 2008-01-28 2009-08-06 Milux Holding Sa An implantable drainage device
EP2240135B1 (en) 2008-01-29 2021-08-04 Implantica Patent Ltd. Apparatus for treating obesity and reflux disease
ES2950024T3 (es) 2008-10-10 2023-10-04 Medicaltree Patent Ltd Dispositivo, sistema y procedimiento de ayuda al corazón
WO2010042032A1 (en) 2008-10-10 2010-04-15 Milux Holding S.A. Fastening means for implantable medcial control assembly
EP2349025B1 (en) 2008-10-10 2015-09-16 Kirk Promotion LTD. A system, an apparatus, and a method for treating a sexual dysfunctional female patient
US10219898B2 (en) 2008-10-10 2019-03-05 Peter Forsell Artificial valve
WO2010042019A1 (en) 2008-10-10 2010-04-15 Milux Holding Sa Heart help device, system, and method
WO2010042046A1 (en) 2008-10-10 2010-04-15 Milux Holding S.A. Apparatus, system and operation method for the treatment of female sexual dysfunction
US10568804B2 (en) * 2008-10-10 2020-02-25 Peter Forsell System, an apparatus, and a method for treating a sexual dysfunctional female patient
US8926572B2 (en) 2008-10-10 2015-01-06 Peter Forsell Stimulation of sexually responsive tissue of the vulva
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2010144817A1 (en) 2009-06-12 2010-12-16 Adagio Pharmaceuticals Ltd. Sublingual apomorphine
US9949812B2 (en) 2009-07-17 2018-04-24 Peter Forsell Vaginal operation method for the treatment of anal incontinence in women
US10952836B2 (en) 2009-07-17 2021-03-23 Peter Forsell Vaginal operation method for the treatment of urinary incontinence in women
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
PT2651357T (pt) 2010-12-16 2020-06-17 Sunovion Pharmaceuticals Inc Películas sublinguais
CA2838109C (en) 2011-04-07 2020-06-09 Nexmed Holdings, Inc. Topical semisolid prostaglandin e1 composition for treating raynaud's disease
CA2745320A1 (en) 2011-07-06 2013-01-06 Duoject Medical Systems Inc. Reconstitution device
WO2015172102A1 (en) * 2014-05-09 2015-11-12 Nexmed Holdings, Inc. Treating female sexual arousal disorder and related symptoms
WO2016172095A1 (en) 2015-04-21 2016-10-27 Cynapsus Therapeutics, Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
US10130578B2 (en) * 2015-07-23 2018-11-20 Johnson & Johnson Consumer Inc. Topical delivery of skin compositions having low pH
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
IL258017B (en) 2018-03-11 2019-10-31 Aquafit Intimate Ltd Cervical device and its uses

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3069322A (en) 1958-05-28 1962-12-18 Bergstrom Sune Pge and pgf
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3639561A (en) 1970-04-29 1972-02-01 Smith Kline French Lab Vaginal suppositories and impregnated tampons
US3852465A (en) 1972-09-21 1974-12-03 Upjohn Co Abortion by myometrial administration of prostaglandins
US4005221A (en) 1974-04-01 1977-01-25 Karim Sultanali M M Use of prostaglandins to induce menstruation
US4217360A (en) 1975-02-27 1980-08-12 Schering Aktiengesellschaft Novel 1,3-benzodioxaneprostanoic acid derivatives and process for the preparation thereof
US4043339A (en) 1976-02-02 1977-08-23 The Upjohn Company Method of and vaginal insert for prostaglandin administration
JPS52156913A (en) 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
AU519132B2 (en) 1978-01-31 1981-11-12 Kureha Kagaku Kogyo K.K. Prostaglandin-steroid conjugates
US4254145A (en) 1978-08-16 1981-03-03 American Cyanamid Company Topical application of prostaglandin hypotensive agents
JPS5573676A (en) 1978-11-30 1980-06-03 Ono Pharmaceut Co Ltd Simulated compound of prostaglandin i2 and its preparation
JPS5589297A (en) 1978-12-28 1980-07-05 Kureha Chem Ind Co Ltd Prostaglandin derivative, its preparation and its drug
SE431821B (sv) 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat
US4311707A (en) 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
USRE30439E (en) 1979-03-12 1980-11-25 The Upjohn Company Treatment of genital tract diseases of domestic animals with prostaglandins
US4317447A (en) 1979-07-19 1982-03-02 Ortho Pharmaceutical Corporation Drug delivery system
US4289785A (en) 1980-08-06 1981-09-15 The Upjohn Company Method and compositions involving prostaglandins
ZA831186B (en) 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4515810A (en) 1983-10-06 1985-05-07 American Cyanamid Company Composition of matter
JPS61249934A (ja) * 1985-04-27 1986-11-07 Nitto Electric Ind Co Ltd 外皮投与用組成物
US4820732A (en) 1985-10-04 1989-04-11 The Upjohn Company Method and compositions for reducing dysfunction in angioplasty procedures
US4955878A (en) 1986-04-04 1990-09-11 Biotechnology, Inc. Kit for preventing or treating arterial dysfunction resulting from angioplasty procedures
US4889845A (en) 1986-06-09 1989-12-26 American Cyanamid Company Vehicle for topical application of pharmaceuticals
US4771004A (en) 1986-08-29 1988-09-13 Iprx, Inc. Method for in vitro determination of transdermal absorption
EP0266968A3 (en) 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent
US4861764A (en) 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
JPS63135333A (ja) 1986-11-26 1988-06-07 Nitto Electric Ind Co Ltd プロスタグランジン類含有貼付剤
US5219885A (en) 1987-02-16 1993-06-15 Froelich Juergen Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
US4801587A (en) 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5082866A (en) 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
US4980378A (en) 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
IT1221826B (it) 1988-06-08 1990-07-12 Medico Harvey Srl Centro Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
SE463851B (sv) 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
JP2910857B2 (ja) 1989-04-04 1999-06-23 ニチバン株式会社 プロスタグランジンｅ１経皮吸収製剤
JP2926749B2 (ja) * 1989-04-25 1999-07-28 吉富製薬株式会社 プロスタグランジン含有液状組成物
US5208031A (en) * 1989-06-06 1993-05-04 Kelly Patrick D Sexual lubricants containing zinc as an anti-viral agent
US5059603A (en) 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
JPH0737389B2 (ja) * 1989-08-29 1995-04-26 久光製薬株式会社 プロスタグランジンｅ１含有の軟膏剤
NZ237899A (en) 1990-04-25 1997-03-24 Vivus Inc Substituted For Alza An apparatus comprising a shaft and a therapeutic composition; suitable to treat erectile dysfunction by insertion in the urethra
US5242391A (en) 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
CA2046069C (en) 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
WO1993000894A1 (en) 1991-07-03 1993-01-21 Scott Nathan E Prostaglandin e2 treatment of impotence
KR930007445A (ko) 1991-10-23 1993-05-20 원본미기재 국소 적용 배합물의 침투 증가방법
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5773457A (en) 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
US5324746A (en) 1993-02-12 1994-06-28 Mckee Rex N Method of treating damaged mucosal and epithelial tissues with misoprostol
US5698589A (en) 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5565466A (en) 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
ES2142409T3 (es) 1993-10-27 2000-04-16 Upjohn Co Prostaglandina e 1 estabilizada.
US5380760A (en) 1993-11-19 1995-01-10 Minnesota Mining And Manufacturing Company Transdermal prostaglandin composition
JPH10505611A (ja) 1995-03-14 1998-06-02 ヴィヴァス・インコーポレーテッド 勃起機能不全を予防するための方法およびキット
US5661178A (en) 1995-09-01 1997-08-26 Allergan Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives
US6036977A (en) 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
ES2191834T3 (es) * 1996-10-24 2003-09-16 Alza Corp Agentes que facilitan la permeacion y destinados para composiciones, dispositivos y procedimientos de aporte transdermico de medicamentos.
US20020004529A1 (en) 1997-10-20 2002-01-10 Gary W. Neal Methods, compositions, and kits for enhancing female sexual desire and responsiveness
US5877216A (en) 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US6031002A (en) 1998-05-01 2000-02-29 Michael Ebert Method for enhancing female sexual response and a composition therefor
US5891915A (en) 1998-05-01 1999-04-06 Wysor; Michael S. Method for enhancing female sexual response and an ointment therefor
US6046240A (en) 1998-05-01 2000-04-04 Harvard Scientific Corporation Methods for treating female sexual dysfunction

Also Published As

Publication number Publication date
KR100660239B1 (ko) 2006-12-20
IL143661A (en) 2006-06-11
AU760112B2 (en) 2003-05-08
IL143661A0 (en) 2002-04-21
CA2354695C (en) 2005-01-25
WO2000033825A2 (en) 2000-06-15
JP4616480B2 (ja) 2011-01-19
EP1137409B1 (en) 2004-05-06
US6486207B2 (en) 2002-11-26
US20020028846A1 (en) 2002-03-07
KR20020068257A (ko) 2002-08-27
HUP0200067A3 (en) 2005-03-29
EP1137409A2 (en) 2001-10-04
DE69917066D1 (de) 2004-06-09
ZA200104697B (en) 2002-08-28
JP2002531494A (ja) 2002-09-24
AU2358600A (en) 2000-06-26
CN1173700C (zh) 2004-11-03
HU229083B1 (en) 2013-07-29
HUP0200067A2 (en) 2002-06-29
HK1039067A1 (en) 2002-04-12
WO2000033825A3 (en) 2000-11-16
DE69917066T2 (de) 2005-04-28
MXPA01005748A (es) 2003-07-14
HK1039067B (zh) 2004-10-08
CN1330543A (zh) 2002-01-09
ES2217878T3 (es) 2004-11-01
BR9916076A (pt) 2001-09-04
CA2354695A1 (en) 2000-06-15
ATE265849T1 (de) 2004-05-15
PT1137409E (pt) 2004-08-31

Similar Documents

Publication Publication Date Title
DK1137409T3 (da) Præparater og fremgangsmåde til lindring af human kvindelig seksuel dysfunktion
BR9916857A (pt) 4 heteroaril diarilaminas
BR0006634A (pt) Extratos de matricária (tanacetum parthenium) contra distúrbios inflamatórios
SE9703693D0 (sv) Novel combination
GB2384084A (en) Methods and apparatus for implementing financial transactions
BR0314354A (pt) Formação para gentes lipofìlicos
GT199900013A (es) Tratamiento de la disfuncion sexual femenina.
DK0722323T3 (da) Præparater indeholdende troxerutin komplekseret med phosphatidylcholin til topisk behandling af erektil impotens
GT199800177A (es) Combinacion eficaz para el tratamiento de la impotencia .
DE59807248D1 (de) Implantatkörper
TWI257869B (en) Skin external composition for improving moisturing effect and skin roughness
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
SE9603725D0 (sv) New teatment
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
YU45103A (sh) Upotreba sarp/1 za lečenje i prevenciju skleroderme
BR0114604A (pt) Tratamento de c‰nceres
BR0012006A (pt) Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr
NO20005548D0 (no) Mykobakterieinhibitorer
ATE361757T1 (de) Stabile fumagillin-formulierung
DK1227826T3 (da) Sammensætninger omfattende et ekstrakt af Perna canaliculus, methylsulfonylmethan og glucosamid samt anvendelsen heraf
DE69721831D1 (de) Aphrodisiakum zur anwendung an den geschlechtsorganen
UA29220A (uk) Спосіб прогнозування розвитку хронічного легеневого серця у робітників пиленебезпечних професій
EA200500126A1 (ru) Композиции и способы лечения сексуальной дисфункции у женщин
ITRM20010261A1 (it) Struttura di protezione per articolazioni e metodo per la sua realizzazione.